Galapagos NV
GLPG
#4623
Rank
A$3.09 B
Marketcap
A$46.93
Share price
-1.50%
Change (1 day)
11.05%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: A$3.09 Billion

As of December 2025 Galapagos NV has a market cap of A$3.09 Billion. This makes Galapagos NV the world's 4623th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025A$3.09 B6.94%
2024A$2.89 B-26.44%
2023A$3.93 B-8.43%
2022A$4.29 B-14.79%
2021A$5.03 B-40.16%
2020A$8.42 B-56.36%
2019A$19.29 B170.83%
2018A$7.12 B15.82%
2017A$6.15 B48.8%
2016A$4.13 B22.17%
2015A$3.38 B385.23%
2014A$0.69 B-0.75%
2013A$0.70 B29.21%
2012A$0.54 B56.33%
2011A$0.34 B-16.94%
2010A$0.41 B47.6%
2009A$0.28 B94.81%
2008A$0.14 B

End of Day market cap according to different sources

On Dec 14th, 2025 the market cap of Galapagos NV was reported to be:

A$3.13 Billion
by Nasdaq info icon info icon
A$3.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
A$424.38 B 13,621.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$772.92 B 24,890.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$174.99 B 5,557.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$602.99 B 19,396.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$0.15 B-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$334.08 B 10,701.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$51.81 B 1,575.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$149.24 B 4,725.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$376.37 B 12,069.09%๐Ÿ‡บ๐Ÿ‡ธ USA